GDPD3 and chronic myelogenous leukemia, BCR-ABL1 positive: To our surprise, Gdpd3-deficient CML stem cells showed a significant decrease in their ability to induce CML, whereas WT-CML stem cells maintained this capacity in a second-round of BMT.